研究性癌症治疗剂

Phase I Clinical Trials Program

The Department of Investigational Cancer Therapeutics conducts broad phase I studies across disease boundaries and molecular targets. We strive to provide outstanding patient care while performing innovative phase I trials with new drugs that may eventually improve the management of cancer.

在部门主席的领导下，副部门主席戴维·洪（David Hong）博士和部门管理员Yagut Retondo的领导下，我们的计划已成为正在寻找新实验性I期疗法的患者，医师和科学家的集中资源最终可能代表癌症研究和治疗方面的进步。188bet体育网址

目标

• To provide novel cancer treatment options to patients with cancer
• To improve treatment options for patients with cancer through research and discovery
• 通过奖学金和出版物为下一代临床研究人员提供教育，教学和培训188bet体育网址

您还可以了解靶向治疗的临床中心，该中心致力于通过将最新的癌症治疗药物从实验室带到临床试验，为我们的患者提供出色的护理。